Public Awareness Low About HPV, HPV Vaccination, HPV-Linked Cancer
THURSDAY, Aug. 14, 2025 -- Public awareness about human papillomavirus (HPV), HPV vaccination, and HPV-associated cancers is low, according to a research letter published online Aug. 14 in JAMA Oncology.
Ashvita Garg, Ph.D., M.P.H., M.B.B.S., from the Medical University of South Carolina, and colleagues conducted a cross-sectional study analyzing the 2017 to 2020 Health Information National Trends Survey (HINTS) 5, cycles 1 to 4, and the 2022 HINTS cycle 6 to quantify awareness of HPV, the HPV vaccines, and HPV's association with cancer.
A total of 22,344 respondents were included in the final sample. The researchers found that 34.3 and 37.6 percent of U.S. adults were unaware of HPV and lacked awareness of the HPV vaccine, respectively. In seven states, mostly from the Midwest and South, lack of HPV awareness exceeded 40 percent; similarly, more than 40 percent of individuals from 13 states -- nine from the Midwest and South -- were unaware of the HPV vaccine. Overall, 70.8 and 28.3 percent of respondents who knew about HPV nationally were unaware that HPV causes oral and cervical cancers, respectively. More than 60 percent of individuals in 45 states and Washington, D.C., lacked awareness that HPV causes oral cancers; lack of awareness that HPV causes cervical cancer was less common (6.9 to 57.4 percent).
"Given the importance of timely HPV vaccination and the risk of early-life exposure, there is a critical need to enhance HPV awareness among adolescents, young adults, parents or caregivers, and pediatric and adult health care professionals," the authors write.
One author disclosed financial ties to Merck.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Circulating Tumor HPV DNA Can ID HPV+OPSCC Years Before Diagnosis
MONDAY, Sept. 22, 2025 -- Circulating tumor human papillomavirus DNA (ctHPVDNA) can be detected in the blood years prior to HPV-associated oropharyngeal squamous cell carcinoma...
Nonadherence to Cervical Cancer Screening Increased After COVID-19 Pandemic
THURSDAY, Sept. 18, 2025 -- Nonadherence to cervical cancer screening in the United States increased after the COVID-19 pandemic, according to a study published online Sept. 10...
Influenza-Linked Hospitalization Rate High in 2024 to 2025 Flu Season
WEDNESDAY, Sept. 17, 2025 -- The cumulative influenza-associated hospitalization rate for the 2024 to 2025 season surpassed all end-of-season rates during the period beginning...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.